查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404643

次世代定序市场规模、份额、趋势分析报告：按技术、按产品、按应用、按工作流程、按最终用途、按地区、细分市场预测，2024-2030 年

Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology (WGS, Targeted Sequencing & Resequencing), By Product (Platform, Consumables), By Application, By Workflow, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 300 Pages | 商品交期: 2-10个工作天内

价格

次世代定序市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球次世代定序市场规模将达到312.6亿美元，2024-2030年复合年增长率为21.12%。

次世代定序（NGS）是一种平行处理技术，可建立具有可扩展性、超高容量和高速度的全基因组序列。此外，医疗保健产业正逐步将NGS纳入医学检测研究、筛检和疾病诊断。它经常用于个人化医疗，以加速药物研发研究方法。

研究人员积极使用RNA定序、全基因组定序、全EXOME和标靶定序等具有各种潜力的定序技术来获得全面的样本分析。与传统的Sanger定序技术相比，NGS 的 DNA 定序成本更低，通量更高。定序前方案、定序后方案和资料分析的自动化程度的提高预计也将对 NGS 市场产生正面影响。透过基因层级的医学分析利用新平台进行个人化医疗开发也是一个关键因素，预计将在预测期内推动 NGS 的需求。

定序产业的其他主要成长趋势包括个人化医疗和伴同性诊断的进步、云端运算和资料整合的进步。此外，随着基因组和蛋白质组资料的可用性不断增加，该市场已经出现，在预测期内呈现出具有高潜在价值的成长途径和机会。全球癌症发生率的增加和先进医疗设施的可用性也推动了市场的成长。根据 GLOBOCAN 2020，2020 年新增癌症患者人数为 1,92,92,789 人，预计 2040 年将增加至 2,88,87,940 人。癌症病例数量的显着增加预计将促进癌症研究，最终加速 NGS 市场的成长。

NGS 诊断技术具有对病毒基因组进行定序并帮助科学家了解突变的潜力。此外，在 COVID-19 疫情期间，世界各国政府正与企业部门合作，将 NGS 技术作为可行的诊断工具推向市场。 2020 年 6 月，美国食品药物管理局向 Illumina Inc. 授予紧急使用授权，以首次使用次世代定序技术进行 COVID-19 诊断。用于定性鑑定 SARS-CoV-2 RNA 的 Illumina COVIDSeq 测试已获得 FDA核准。因此，次世代定序（NGS）技术的使用预计会在大流行期间增加。

次世代定序市场报告亮点

  • 从应用来看，肿瘤学领域的收益占有率最大，2023年为27.31%。该细分市场的成长在很大程度上归因于癌症盛行率的增加和定序技术的进步。
  • 由于这些机构基于应用的利用率的增加和肿瘤学研究的增加，预计学术研究领域在预测期内将显着增长。治疗药物、肿瘤学和基因组研究也在取得进展，导致市场成长。
  • 由于医疗保健基础设施的广泛开拓、各国积极采用先进技术以及主要企业的存在，预计亚太地区的市场在预测期内将显着增长。
  • 2023年，北美市场占据主导地位，份额为49.35%。由于高研发投资和技术先进的医疗保健研究框架的存在，预计该地区 WGS 的发展也将成为预测期内北美 NGS 市场成长的关键因素。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 成本结构分析
  • 从使用者观点分析
    • 消费行为分析
  • 流程成本分析
  • 主要最终用户名单
    • 按类型
    • 副产品
    • 按美国各州
  • 技术概述
    • 技术时间表
  • COVID-19感染疾病的影响
    • 对供应链的影响
    • COVID-19 与 NG 之间的关係
  • 市场趋势及展望
  • 市场区隔和范围
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 营商环境分析
    • SWOT 分析；按因素（政治/法律、经济、技术）
    • 波特五力分析
  • 主要交易及策略联盟分析
    • 合资企业
    • 併购
    • 许可和合作伙伴关係
    • 技术合作

第四章科技业务分析

  • 次世代定序市场：技术波动分析
  • 标靶定序和定序
  • 全基因组序列测定
  • 全EXOME定序
  • 其他的

第五章 产品经营分析

  • 次世代定序市场：产品变异分析
  • 平台
  • 消耗品

第六章 应用业务分析

  • 次世代定序市场：应用变化分析
  • 肿瘤学
    • 诊断和筛检
    • 研究
  • 临床研究
    • 感染疾病
    • 特发性疾病
    • 遗传疾病
    • 非传染性疾病/其他疾病
  • 生殖健康
    • Nipt
    • Pgt
    • 新生儿基因筛检
    • 单基因分析
  • Hla 分型/免疫系统监测
  • 宏基因体学、流行病学、药物研发
  • 农业基因组学与法医学
  • 消费者基因体学

第7章 工作流程业务分析

  • 次世代定序市场：工作流程变化分析
  • 前序
  • 顺序
  • 资料分析

第 8 章最终用途业务分析

  • 次世代定序市场：最终用途变异分析
  • 学术研究
  • 临床调查
  • 医院和诊所
  • 製药和生物技术公司
  • 其他的

第 9 章次世代定序市场：按产品、技术、应用、工作流程和最终用途的区域估计和趋势分析

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第10章竞争形势

  • 公司分类
  • 策略规划
  • 2023 年公司市场占有率分析
  • 公司简介
    • Thermo Fisher Scientific, Inc.
    • Qiagen NV
    • Illumina, Inc.
    • F. Hoffmann-La Roche Ag
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Pieriandx
    • Oxford Nanopore Technologies Plc
    • Partek Incorporated
    • Eurofins Scientific
    • Dnastar
    • Sophia Genetics.
    • Fabric Genomics, Inc.
    • Laboratory Corporation Of America
    • Syapse, Inc.
    • Personalis, Inc.
    • 10x Genomics
    • Dnanexus, Inc.
    • Centogene NV
    • Invitae Corporation
    • Genedx, Llc
Product Code: 978-1-68038-428-4

Next Generation Sequencing Market Growth & Trends:

The global next generation sequencing market size is expected to reach USD 31.26 billion by 2030, registering a CAGR of 21.12% from 2024 to 2030, according to a new report by Grand View Research, Inc. Next-generation Sequencing (NGS) is a parallel processing technique that can establish the sequence of nucleotides in a whole genome with scalability, ultra-high capacity, and fast speed. Furthermore, in the healthcare industry, NGS is gradually being incorporated into medical laboratory research, screening, and disease diagnoses. In personalized medicine, it has been frequently utilized to accelerate the drug research process.

Different potential sequencing methods such as RNA sequencing, whole-genome sequencing, and whole-exome and targeted sequencing amongst others are prominently used by researchers to get comprehensive sample analysis. When compared to the traditional Sanger sequencing technology, NGS is less expensive and provides higher throughput for DNA sequencing. The growing automation in the pre-sequencing protocols, post-sequencing protocols, and data analysis is also projected to have a positive impact on the NGS market. The utilization of novel platforms for the development of personalized medicine by medical analysis at a genetic level is also a significant factor, which is expected to enhance demand for NGS over the forecast period.

Besides, there are other significant growth trends that are being witnessed in the sequencing industry, such as the development of personalized medicine and companion diagnostics, growing advancements in cloud computing, and data integration. Furthermore, the easy availability of genomic and proteomic data has poised this market to exhibit potentially high-value avenues and opportunities for growth over the forecast period. The market growth is also being fueled by an increase in the global prevalence of cancer and the availability of sophisticated healthcare facilities. As per GLOBOCAN 2020, there have been 1,92,92,789 new cancer cases in 2020, with the number expected to rise to 2,88,87,940 by 2040. Such a substantial rise in the number of cancer cases is estimated to leverage cancer research which will eventually accelerate the NGS market growth.

The NGS diagnostic techniques have the potential to determine a virus's genomic sequence and aid scientists in their understanding of mutations. Furthermore, throughout the COVID-19 epidemic, governments across the globe have been collaborating with the corporate sector to introduce NGS technology to the market as a viable diagnostic tool. The US Food and Drug Administration granted Illumina Inc. a case of emergency use permit for the first COVID-19 diagnostic using the next-generation sequence technique in June 2020. The Illumina COVIDSeq Test for qualitative identification of SARS-CoV-2 RNA has been approved by the FDA. As a result, the usage of next-generation sequencing (NGS) technologies is projected to increase during the pandemic.

Next Generation Sequencing Market Report Highlights:

  • By application, the oncology segment held the largest revenue share of 27.31% in 2023. The segment growth is prominently attributed to increasing in the prevalence of cancer and advancements in sequencing technologies
  • The academic research segment is expected to grow lucratively over the forecast period due to an increase in application-based usage in these institutes and a rise in oncology research. In addition, advancements in R&D for therapeutics, oncology, and genomics research led to the growth of the market
  • In Asia Pacific, the market is expected to grow considerably during the forecast period owing to extensive developments in healthcare infrastructure, the positive approach of respective countries for adoption of advanced technologies, and the presence of key players
  • North America dominated the market with a share of 49.35% in 2023, due to the presence of high R&D investment, and availability of technologically advanced healthcare research framework, the development of WGS in the region is also expected to serve as a critical factor for the growth of the North America NGS market throughout the forecast period

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Research Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Primary Research
    • 1.3.4 Details Of Primary Research
      • 1.3.4.1 Primary Interviews: Statistics
      • 1.3.4.1.1 Geographical Distribution Of Primary Interviews
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Objectives
    • 1.6.1 Objective 1
    • 1.6.2 Objective 2

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Cost Structure Analysis
  • 3.3 User Perspective Analysis
    • 3.3.1 Consumer Behavior Analysis
      • 3.3.1.1 Market Influencer Analysis
  • 3.4 Procedure Cost Analysis
  • 3.5 List Of Key End Users
    • 3.5.1 By Type
    • 3.5.2 By Product
    • 3.5.3 By U.S. State
  • 3.6 Technology Overview
    • 3.6.1 Technology Timeline
  • 3.7 Impact Of Covid-19 Pandemic
    • 3.7.1 Impact On The Supply Chain
    • 3.7.2 Association Of Covid-19 With Ngs
  • 3.8 Market Trends And Outlook
  • 3.9 Market Segmentation And Scope
  • 3.10 Market Dynamics
    • 3.10.1 Market Driver Analysis
      • 3.10.1.1 Exponentially Decreasing Costs For Genetic Sequencing
      • 3.10.1.2 Development Of Companion Diagnostics And Personalized Medicine
      • 3.10.1.3 Rise In Competition Among Prominent Market Entities
      • 3.10.1.4 Rising Clinical Opportunity For Ngs Technology
      • 3.10.1.5 Technological Advancements In Cloud Computing And Data Integration
      • 3.10.1.6 Growing Healthcare Expenditure Supporting Development Of Effective Diagnostic & Therapeutic Procedures For Cancer
      • 3.10.1.7 Increasing Prevalence Of Cancer
    • 3.10.2 Market Restraint Analysis
      • 3.10.2.1 Lack Of Computational Efficiency For Data Management
      • 3.10.2.2 Non-Value-Based Ngs Reimbursement Policy And Regulation Status
      • 3.10.2.3 Challenges Associated With Ngs Implementation
  • 3.11 Business Environment Analysis
    • 3.11.1 Swot Analysis; By Factor (Political & Legal, Economic, And Technological)
    • 3.11.2 Porter's Five Forces Analysis
  • 3.12 Major Deals And Strategic Alliances Analysis
    • 3.12.1 Joint Ventures
    • 3.12.2 Mergers & Acquisitions
    • 3.12.3 Licensing & Partnerships
    • 3.12.4 Technology Collaborations

Chapter 4 Technology Business Analysis

  • 4.1 Next Generation Sequencing Market: Technology Movement Analysis
  • 4.2 Targeted Sequencing & Resequencing
    • 4.2.1 Targeted Sequencing & Resequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.1.1 Dna-Based Targeted Sequencing & Resequencing
      • 4.2.1.1.1 Dna-Based Targeted Sequencing & Resequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.1.2 Rna-Based Targeted Sequencing & Resequencing
      • 4.2.1.2.1 Rna -Based Targeted Sequencing & Resequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.3 Whole Genome Sequencing
    • 4.3.1 Whole Genome Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.4 Whole Exome Sequencing
    • 4.4.1 Whole Exome Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.5 Others
    • 4.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 Product Business Analysis

  • 5.1 Next Generation Sequencing Market: Product Movement Analysis
  • 5.2 Platforms
    • 5.2.1 Platforms Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.1 Sequencing
      • 5.2.1.1.1 Sequencing Platforms Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2 Data Analysis
      • 5.2.1.2.1 Data Analysis Platforms Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 Consumables
    • 5.3.1 Consumables Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.2 Sample Preparation
      • 5.3.2.1 Sample Preparation Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.3 Target Enrichment
      • 5.3.3.1 Target Enrichment Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.4 Others
      • 5.3.4.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Application Business Analysis

  • 6.1 Next Generation Sequencing Market: Application Movement Analysis
  • 6.2 Oncology
    • 6.2.1 Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 Diagnostics & Screening
      • 6.2.2.1 Diagnostics & Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2 Oncology Screening
      • 6.2.2.2.1 Oncology Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2.2 Sporadic Cancer Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2.3 Inherited Cancer Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.3 Companion Diagnostics
      • 6.2.2.3.1 Companion Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.4 Other Diagnostics
      • 6.2.2.4.1 Other Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.3 Research Studies
      • 6.2.3.1 Research Studies Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Clinical Investigation
    • 6.3.1 Clinical Investigation Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2 Infectious Diseases
      • 6.3.2.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.3 Idiopathic Diseases
      • 6.3.3.1 Idiopathic Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.4 Inherited Diseases
      • 6.3.4.1 Inherited Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.5 Non-Communicable/Other Diseases
      • 6.3.5.1 Non-Communicable/Other Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.4 Reproductive Health
    • 6.4.1 Reproductive Health Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2 Nipt
      • 6.4.2.1 Nipt Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.2 Aneuploidy
      • 6.4.2.2.1 Aneuploidy Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.3 Microdeletions
      • 6.4.2.3.1 Microdeletions Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.3 Pgt
      • 6.4.3.1 Pgt Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.4 Newborn Genetic Screening
      • 6.4.4.1 Newborn Genetic Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.5 Single Gene Analysis
      • 6.4.5.1 Single Gene Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.5 Hla Typing/Immune System Monitoring
    • 6.5.1 Hla Typing/Immune System Monitoring Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.6 Metagenomics, Epidemiology & Drug Development
    • 6.6.1 Metagenomics, Epidemiology & Drug Development Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.7 Agrigenomics & Forensics
    • 6.7.1 Agrigenomics & Forensics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.8 Consumer Genomics
    • 6.8.1 Consumer Genomics Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Workflow Business Analysis

  • 7.1 Next Generation Sequencing Market: Workflow Movement Analysis
  • 7.2 Presequencing
    • 7.2.1 Pre-Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.1 Ngs Library Preparation Kits
      • 7.2.1.1.1 Ngs Library Preparation Kits Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.2 Semiautomated Library Preparation
      • 7.2.1.2.1 Semiautomated Library Preparation Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.3 Automated Library Preparation
      • 7.2.1.3.1 Automated Library Preparation Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.3 Sequencing
    • 7.3.1 Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4 Data Analysis
    • 7.4.1 Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.4.2 Primary Data Ngs Analysis
      • 7.4.2.1 Primary Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.4.3 Secondary Data Analysis
      • 7.4.3.1 Secondary Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.4.4 Tertiary Data Analysis
      • 7.4.4.1 Tertiary Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 End-Use Business Analysis

  • 8.1 Next Generation Sequencing Market: End-Use Movement Analysis
  • 8.2 Academic Research
    • 8.2.1 Academic Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3 Clinical Research
    • 8.3.1 Clinical Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4 Hospitals & Clinics
    • 8.4.1 Hospitals & Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5 Pharmaceutical & Biotech Entities
    • 8.5.1 Pharmaceutical & Biotech Entities Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6 Other Users
    • 8.6.1 Other Users Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 Next Generation Sequencing Market: Regional Estimates And Trend Analysis, By Product, Technology, Application, Workflow, & End-Use

  • 9.1 North America
    • 9.1.1 North America Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.1.2 U.S.
      • 9.1.2.1 Key Country Dynamics
      • 9.1.2.2 Target Disease Prevalence
      • 9.1.2.3 Competitive Scenario
      • 9.1.2.4 Regulatory Framework
      • 9.1.2.5 Reimbursement Scenario
      • 9.1.2.6 U.S. Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.1.3 Canada
      • 9.1.3.1 Key Country Dynamics
      • 9.1.3.2 Target Disease Prevalence
      • 9.1.3.3 Competitive Scenario
      • 9.1.3.4 Regulatory Framework
      • 9.1.3.5 Reimbursement Scenario
      • 9.1.3.6 Canada Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.2 Europe
    • 9.2.1 Europe Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2 Uk
      • 9.2.2.1 Key Country Dynamics
      • 9.2.2.2 Target Disease Prevalence
      • 9.2.2.3 Competitive Scenario
      • 9.2.2.4 Regulatory Framework
      • 9.2.2.5 Reimbursement Scenario
      • 9.2.2.6 Uk Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.3 Germany
      • 9.2.3.1 Key Country Dynamics
      • 9.2.3.2 Target Disease Prevalence
      • 9.2.3.3 Competitive Scenario
      • 9.2.3.4 Regulatory Framework
      • 9.2.3.5 Reimbursement Scenario
      • 9.2.3.6 Germany Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.4 France
      • 9.2.4.1 Key Country Dynamics
      • 9.2.4.2 Target Disease Prevalence
      • 9.2.4.3 Competitive Scenario
      • 9.2.4.4 Regulatory Framework
      • 9.2.4.5 Reimbursement Scenario
      • 9.2.4.6 France Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.5 Spain
      • 9.2.5.1 Key Country Dynamics
      • 9.2.5.2 Competitive Scenario
      • 9.2.5.3 Regulatory Framework
      • 9.2.5.4 Reimbursement Scenario
      • 9.2.5.5 Spain Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.6 Italy
      • 9.2.6.1 Key Country Dynamics
      • 9.2.6.2 Target Disease Prevalence
      • 9.2.6.3 Competitive Scenario
      • 9.2.6.4 Regulatory Framework
      • 9.2.6.5 Reimbursement Scenario
      • 9.2.6.6 Italy Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.7 Denmark
      • 9.2.7.1 Key Country Dynamics
      • 9.2.7.2 Target Disease Prevalence
      • 9.2.7.3 Competitive Scenario
      • 9.2.7.4 Regulatory Framework
      • 9.2.7.5 Reimbursement Scenario
      • 9.2.7.6 Denmark Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.8 Sweden
      • 9.2.8.1 Key Country Dynamics
      • 9.2.8.2 Target Disease Prevalence
      • 9.2.8.3 Competitive Scenario
      • 9.2.8.4 Regulatory Framework
      • 9.2.8.5 Reimbursement Scenario
      • 9.2.8.6 Sweden Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.9 Norway
      • 9.2.9.1 Key Country Dynamics
      • 9.2.9.2 Target Disease Prevalence
      • 9.2.9.3 Competitive Scenario
      • 9.2.9.4 Regulatory Framework
      • 9.2.9.5 Reimbursement Scenario
      • 9.2.9.6 Norway Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.3 Asia Pacific
    • 9.3.1 Asia Pacific Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2 Japan
      • 9.3.2.1 Key Country Dynamics
      • 9.3.2.2 Target Disease Prevalence
      • 9.3.2.3 Competitive Scenario
      • 9.3.2.4 Regulatory Framework
      • 9.3.2.5 Reimbursement Scenario
      • 9.3.2.6 Japan Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3 China
      • 9.3.3.1 Key Country Dynamics
      • 9.3.3.2 Target Disease Prevalence
      • 9.3.3.3 Competitive Scenario
      • 9.3.3.4 Regulatory Framework
      • 9.3.3.5 Reimbursement Scenario
      • 9.3.3.6 China Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4 India
      • 9.3.4.1 Key Country Dynamics
      • 9.3.4.2 Target Disease Prevalence
      • 9.3.4.3 Competitive Scenario
      • 9.3.4.4 Regulatory Framework
      • 9.3.4.5 Reimbursement Scenario
      • 9.3.4.6 India Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.5 Australia
      • 9.3.5.1 Key Country Dynamics
      • 9.3.5.2 Target Disease Prevalence
      • 9.3.5.3 Competitive Scenario
      • 9.3.5.4 Regulatory Framework
      • 9.3.5.5 Reimbursement Scenario
      • 9.3.5.6 Australia Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.6 Thailand
      • 9.3.6.1 Key Country Dynamics
      • 9.3.6.2 Target Disease Prevalence
      • 9.3.6.3 Competitive Scenario
      • 9.3.6.4 Regulatory Framework
      • 9.3.6.5 Reimbursement Scenario
      • 9.3.6.6 Thailand Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.7 South Korea
      • 9.3.7.1 Key Country Dynamics
      • 9.3.7.2 Target Disease Prevalence
      • 9.3.7.3 Competitive Scenario
      • 9.3.7.4 Regulatory Framework
      • 9.3.7.5 Reimbursement Scenario
      • 9.3.7.6 South Korea Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4 Latin America
    • 9.4.1 Latin America Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2 Brazil
      • 9.4.2.1 Key Country Dynamics
      • 9.4.2.2 Target Disease Prevalence
      • 9.4.2.3 Competitive Scenario
      • 9.4.2.4 Regulatory Framework
      • 9.4.2.5 Reimbursement Scenario
      • 9.4.2.6 Brazil Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3 Mexico
      • 9.4.3.1 Key Country Dynamics
      • 9.4.3.2 Target Disease Prevalence
      • 9.4.3.3 Competitive Scenario
      • 9.4.3.4 Regulatory Framework
      • 9.4.3.5 Reimbursement Scenario
      • 9.4.3.6 Mexico Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4 Argentina
      • 9.4.4.1 Key Country Dynamics
      • 9.4.4.2 Target Disease Prevalence
      • 9.4.4.3 Regulatory Framework
      • 9.4.4.4 Reimbursement Scenario
      • 9.4.4.5 Argentina Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5 MEA
    • 9.5.1 MEA Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2 South Africa
      • 9.5.2.1 Key Country Dynamics
      • 9.5.2.2 Target Disease Prevalence
      • 9.5.2.3 Competitive Scenario
      • 9.5.2.4 Regulatory Framework
      • 9.5.2.5 Reimbursement Scenario
      • 9.5.2.6 South Africa Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3 Saudi Arabia
      • 9.5.3.1 Key Country Dynamics
      • 9.5.3.2 Target Disease Prevalence
      • 9.5.3.3 Competitive Scenario
      • 9.5.3.4 Regulatory Framework
      • 9.5.3.5 Reimbursement Scenario
      • 9.5.3.6 Saudi Arabia Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4 UAE
      • 9.5.4.1 Key Country Dynamics
      • 9.5.4.2 Target Disease Prevalence
      • 9.5.4.3 Competitive Scenario
      • 9.5.4.4 Regulatory Framework
      • 9.5.4.5 Reimbursement Scenario
      • 9.5.4.6 UAE Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5 Kuwait
      • 9.5.5.1 Key Country Dynamics
      • 9.5.5.2 Target Disease Prevalence
      • 9.5.5.3 Competitive Scenario
      • 9.5.5.4 Regulatory Framework
      • 9.5.5.5 Reimbursement Scenario
      • 9.5.5.6 Kuwait Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10 Competitive Landscape

  • 10.1 Company Categorization
  • 10.2 Strategy Mapping
  • 10.3 Company Market Share Analysis, 2023
  • 10.4 Company Profiles
    • 10.4.1 Thermo Fisher Scientific, Inc.
      • 10.4.1.1 Company Overview
      • 10.4.1.2 Life Technologies Corporation
      • 10.4.1.2.1 Company Overview
      • 10.4.1.3 Financial Performance
      • 10.4.1.4 Product Benchmarking
      • 10.4.1.5 Strategic Initiatives
    • 10.4.2 Qiagen N.V.
      • 10.4.2.1 Company Overview
      • 10.4.2.2 Clc Bio
      • 10.4.2.2.1 Company Overview
      • 10.4.2.3 Financial Performance
      • 10.4.2.4 Product Benchmarking
      • 10.4.2.5 Strategic Initiatives
    • 10.4.3 Illumina, Inc.
      • 10.4.3.1 Company Overview
      • 10.4.3.2 Edico Genome
      • 10.4.3.2.1 Company Overview
      • 10.4.3.3 Financial Performance
      • 10.4.3.4 Product Benchmarking
      • 10.4.3.5 Strategic Initiatives
    • 10.4.4 F. Hoffmann-La Roche Ag
      • 10.4.4.1 Company Overview
      • 10.4.4.2 Foundation Medicine
      • 10.4.4.2.1 Company Overview
      • 10.4.4.3 Financial Performance
      • 10.4.4.4 Product Benchmarking
      • 10.4.4.5 Strategic Initiatives
    • 10.4.5 Agilent Technologies, Inc.
      • 10.4.5.1 Company Overview
      • 10.4.5.2 Financial Performance
      • 10.4.5.3 Product Benchmarking
      • 10.4.5.4 Strategic Initiatives
    • 10.4.6 Bio-Rad Laboratories, Inc.
      • 10.4.6.1 Company Overview
      • 10.4.6.2 Gnubio
      • 10.4.6.2.1 Company Overview
      • 10.4.6.3 Financial Performance
      • 10.4.6.4 Product Benchmarking
      • 10.4.6.5 Strategic Initiatives
    • 10.4.7 Pieriandx
      • 10.4.7.1 Company Overview
      • 10.4.7.2 Tute Genomics
      • 10.4.7.2.1 Company Overview
      • 10.4.7.2.2 Knome, Inc.
      • 10.4.7.2.2.1 Company Overview
      • 10.4.7.3 Product Benchmarking
      • 10.4.7.4 Strategic Initiatives
    • 10.4.8 Oxford Nanopore Technologies Plc
      • 10.4.8.1 Company Overview
      • 10.4.8.2 Financial Performance
      • 10.4.8.3 Product Benchmarking
      • 10.4.8.4 Strategic Initiatives
    • 10.4.9 Partek Incorporated
      • 10.4.9.1 Company Overview
      • 10.4.9.2 Product Benchmarking
      • 10.4.9.3 Strategic Initiatives
    • 10.4.10 Eurofins Scientific
      • 10.4.10.1 Company Overview
      • 10.4.10.2 Eurofins Gatc Biotech Gmbh
      • 10.4.10.2.1 Company Overview
      • 10.4.10.3 Financial Performance
      • 10.4.10.4 Product Benchmarking
      • 10.4.10.5 Strategic Initiatives
    • 10.4.11 Dnastar
      • 10.4.11.1 Company Overview
      • 10.4.11.2 Product Benchmarking
      • 10.4.11.3 Strategic Initiatives
    • 10.4.12 Sophia Genetics.
      • 10.4.12.1 Company Overview
      • 10.4.12.2 Financial Performance
      • 10.4.12.3 Product Benchmarking
      • 10.4.12.4 Strategic Initiatives
    • 10.4.13 Fabric Genomics, Inc.
      • 10.4.13.1 Company Overview
      • 10.4.13.2 Financial Performance
      • 10.4.13.3 Product Benchmarking
      • 10.4.13.4 Strategic Initiatives
    • 10.4.14 Laboratory Corporation Of America
      • 10.4.14.1 Company Overview
      • 10.4.14.2 Financial Performance
      • 10.4.14.3 Product Benchmarking
      • 10.4.14.4 Strategic Initiatives
    • 10.4.15 Syapse, Inc.
      • 10.4.15.1 Company Overview
      • 10.4.15.2 Product Benchmarking
      • 10.4.15.3 Strategic Initiatives
    • 10.4.16 Personalis, Inc.
      • 10.4.16.1 Company Overview
      • 10.4.16.2 Financial Performance
      • 10.4.16.3 Product Benchmarking
      • 10.4.16.4 Strategic Initiatives
    • 10.4.17 10x Genomics
      • 10.4.17.1 Company Overview
      • 10.4.17.2 Financial Performance
      • 10.4.17.3 Product Benchmarking
      • 10.4.17.4 Strategic Initiatives
    • 10.4.18 Dnanexus, Inc.
      • 10.4.18.1 Company Overview
      • 10.4.18.2 Product Benchmarking
      • 10.4.18.3 Strategic Initiatives
    • 10.4.19 Centogene N.V.
      • 10.4.19.1 Company Overview
      • 10.4.19.2 Financial Performance
      • 10.4.19.3 Product Benchmarking
      • 10.4.19.4 Strategic Initiatives
    • 10.4.20 Invitae Corporation
      • 10.4.20.1 Company Overview
      • 10.4.20.2 Financial Performance
      • 10.4.20.3 Product Benchmarking
      • 10.4.20.4 Strategic Initiatives
    • 10.4.21 Genedx, Llc
      • 10.4.21.1 Company Overview
      • 10.4.21.2 Financial Performance
      • 10.4.21.3 Product Benchmarking
      • 10.4.21.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Country share estimation
  • Table 4 Healthcare expenditure
  • Table 5 NGS top platforms
  • Table 6 Base pairs sequenced using WGS, WES, and targeted sequencing & resequencing
  • Table 7 Clonal amplification products in the market
  • Table 8 North America next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 9 North America next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 10 North America next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 12 North America NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 13 North America NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 14 North America next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 15 North America next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 16 North America targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 17 North America next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 18 North America NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 19 North America NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 20 North America next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 21 US next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 22 US next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 23 US next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 24 US next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 25 US NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 26 US NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 27 US next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 28 US next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 29 US targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 30 US next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 31 US NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 32 US NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 33 US next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Canada next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 35 Canada next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 36 Canada next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 37 Canada next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 38 Canada NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 39 Canada NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 40 Canada next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 41 Canada next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 42 Canada targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 43 Canada next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 44 Canada NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 45 Canada NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 46 Canada next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Europe next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 48 Europe next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 49 Europe next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 50 Europe next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 51 Europe NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 52 Europe NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 53 Europe next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 54 Europe next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 55 Europe targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 56 Europe next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 57 Europe NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 58 Europe NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 59 Europe next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Germany next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 61 Germany next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 62 Germany next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 63 Germany next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 64 Germany NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 65 Germany NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 66 Germany next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 67 Germany next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 68 Germany targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 69 Germany next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 70 Germany NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 71 Germany NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 72 Germany next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 73 UK next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 74 UK next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 75 UK next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 76 UK next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 77 UK NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 78 UK NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 79 UK next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 80 UK next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 81 UK targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 82 UK next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 83 UK NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 84 UK NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 85 UK next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Spain next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 87 Spain next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 88 Spain next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 89 Spain next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 90 Spain NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 91 Spain NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 92 Spain next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 93 Spain next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 94 Spain targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 95 Spain next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 96 Spain NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 97 Spain NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 98 Spain next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 99 France next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 100 France next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 101 France next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 102 France next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 103 France NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 104 France NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 105 France next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 106 France next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 107 France targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 108 France next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 109 France NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 110 France NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 111 France next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 112 Italy next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 113 Italy next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 114 Italy next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 115 Italy next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 116 Italy NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 117 Italy NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 118 Italy next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 119 Italy next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 120 Italy targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 121 Italy next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 122 Italy NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 123 Italy NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 124 Italy next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 125 Italy next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 126 Denmark next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 127 Denmark next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 128 Denmark next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 129 Denmark next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 130 Denmark NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 131 Denmark NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 132 Denmark next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 133 Denmark next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 134 Denmark targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 135 Denmark next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 136 Denmark NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 137 Denmark NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 138 Denmark next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 139 Norway next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 140 Norway next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 141 Norway next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 142 Norway next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 143 Norway NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 144 Norway NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 145 Norway next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 146 Norway next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 147 Norway targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 148 Norway next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 149 Norway NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 150 Norway NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 151 Norway next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 152 Sweden next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 153 Sweden next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 154 Sweden next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 155 Sweden next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 156 Sweden NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 157 Sweden NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 158 Sweden next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 159 Sweden next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 160 Sweden targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 161 Sweden next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 162 Sweden NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 163 Sweden NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 164 Sweden next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 165 Asia Pacific next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 166 Asia Pacific next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 167 Asia Pacific next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 168 Asia Pacific next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 169 Asia Pacific NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 170 Asia Pacific NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 171 Asia Pacific next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 172 Asia Pacific next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 173 Asia Pacific targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 174 Asia Pacific next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 175 Asia Pacific NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 176 Asia Pacific NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 177 Asia Pacific next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 178 Japan next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 179 Japan next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 180 Japan next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 181 Japan next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 182 Japan NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 183 Japan NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 184 Japan next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 185 Japan next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 186 Japan targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 187 Japan next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 188 Japan NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 189 Japan NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 190 Japan next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 191 China next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 192 China next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 193 China next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 194 China next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 195 China NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 196 China NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 197 China next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 198 China next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 199 China targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 200 China next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 201 China NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 202 China NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 203 China next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 204 India next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 205 India next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 206 India next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 207 India next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 208 India NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 209 India NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 210 India next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 211 India next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 212 India targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 213 India next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 214 India NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 215 India NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 216 India next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 217 South Korea next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 218 South Korea next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 219 South Korea next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 220 South Korea next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 221 South Korea NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 222 South Korea NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 223 South Korea next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 224 South Korea next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 225 South Korea targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 226 South Korea next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 227 South Korea NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 228 South Korea NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 229 South Korea next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 230 Australia next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 231 Australia next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 232 Australia next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 233 Australia next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 234 Australia NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 235 Australia NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 236 Australia next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 237 Australia next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 238 Australia targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 239 Australia next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 240 Australia NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 241 Australia NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 242 Australia next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 243 Thailand next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 244 Thailand next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 245 Thailand next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 246 Thailand next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 247 Thailand NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 248 Thailand NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 249 Thailand next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 250 Thailand next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 251 Thailand targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 252 Thailand next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 253 Thailand NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 254 Thailand NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 255 Thailand next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 256 Latin America next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 257 Latin America next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 258 Latin America next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 259 Latin America next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 260 Latin America NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 261 Latin America NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 262 Latin America next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 263 Latin America next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 264 Latin America targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 265 Latin America next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 266 Latin America NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 267 Latin America NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 268 Latin America next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 269 Brazil next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 270 Brazil next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Next Generation Sequencing, Market Segmentation
  • Fig. 8 Market Snapshot, 2023
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Next Generation Sequencing Market: Product Movement Analysis
  • Fig. 16 Global Next Generation Sequencing Market, for Platforms, 2018 - 2030 (USD Million)
  • Fig. 17 Global Next Generation Sequencing Market, for Sequencing, 2018 - 2030 (USD Million)
  • Fig. 18 Global Next Generation Sequencing Market, for Data Analysis, 2018 - 2030 (USD Million)
  • Fig. 19 Global Next Generation Sequencing Market, for Consumables, 2018 - 2030 (USD Million)
  • Fig. 20 Global Next Generation Sequencing Market, for Sample Preparation, 2018 - 2030 (USD Million)
  • Fig. 21 Global Next Generation Sequencing Market, for Target Enrichment, 2018 - 2030 (USD Million)
  • Fig. 22 Global Next Generation Sequencing Market: Application, Movement Analysis
  • Fig. 23 Global Next Generation Sequencing Market, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 24 Global Next Generation Sequencing Market, for Diagnostics & Screening, 2018 - 2030 (USD Million)
  • Fig. 25 Global Next Generation Sequencing Market, for Screening, 2018 - 2030 (USD Million)
  • Fig. 26 Global Next Generation Sequencing Market, for Sporadic Cancer, 2018 - 2030 (USD Million)
  • Fig. 27 Global Next Generation Sequencing Market, for Inherited Cancer, 2018 - 2030 (USD Million)
  • Fig. 28 Global Next Generation Sequencing Market, for Companion Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 29 Global Next Generation Sequencing Market, for Other Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 30 Global Next Generation Sequencing Market, for Research Studies, 2018 - 2030 (USD Million)
  • Fig. 31 Global Next Generation Sequencing Market, for Clinical Investigation, 2018 - 2030 (USD Million)
  • Fig. 32 Global Next Generation Sequencing Market for Infectious Diseases 2018 - 2030 (USD Million)
  • Fig. 33 Global Next Generation Sequencing Market, for Idiopathic Diseases, 2018 - 2030 (USD Million)
  • Fig. 34 Global Next Generation Sequencing Market, for Inherited Diseases, 2018 - 2030 (USD Million)
  • Fig. 35 Global Next Generation Sequencing Market, for Non-Communicable/Other Diseases, 2018 - 2030 (USD Million)
  • Fig. 36 Global Next Generation Sequencing Market, for Reproductive Health, 2018 - 2030 (USD Million)
  • Fig. 37 Global Next Generation Sequencing Market, for NIPT, 2018 - 2030 (USD Million)
  • Fig. 38 Global Next Generation Sequencing Market for Aneuploidy, 2018 - 2030 (USD Million)
  • Fig. 39 Global Next Generation Sequencing Market, for Microdeletions, 2018 - 2030 (USD Million)
  • Fig. 40 Global Next Generation Sequencing Market, for PGT, 2018 - 2030 (USD Million)
  • Fig. 41 Global Next Generation Sequencing Market for Newborn Genetic Screening, 2018 - 2030 (USD Million)
  • Fig. 42 Global Next Generation Sequencing Market, for Single Gene Analysis, 2018 - 2030 (USD Million)
  • Fig. 43 Global Next Generation Sequencing Market, for HLA Typing/Immune System Monitoring, 2018 - 2030 (USD Million)
  • Fig. 44 Global Next Generation Sequencing Market, for Metagenomics, Epidemiology & Drug Development, 2018 - 2030 (USD Million)
  • Fig. 45 Global Next Generation Sequencing Market for Agrigenomics & Forensics, 2018 - 2030 (USD Million)
  • Fig. 46 Global Next Generation Sequencing Market, for Consumer Genomics, 2018 - 2030 (USD Million)
  • Fig. 47 Global Next Generation Sequencing Market: Technology Movement Analysis
  • Fig. 48 Global Next Generation Sequencing Market for Whole Genome Sequencing, 2018 - 2030 (USD Million)
  • Fig. 49 Global Next Generation Sequencing Market, for Whole Exome Sequencing, 2018 - 2030 (USD Million)
  • Fig. 50 Global Next Generation Sequencing Market, for Targeted Sequencing & Resequencing, 2018 - 2030 (USD Million)
  • Fig. 51 Global Next Generation Sequencing Market, for DNA-based, 2018 - 2030 (USD Million)
  • Fig. 52 Global Next Generation Sequencing Market for RNA-based, 2018 - 2030 (USD Million)
  • Fig. 53 Global Next Generation Sequencing Market: Workflow Movement Analysis
  • Fig. 54 Global Next Generation Sequencing Market, for Pre-Sequencing, 2018 - 2030 (USD Million)
  • Fig. 55 Global Next Generation Sequencing Market, for Library Preparation, 2018 - 2030 (USD Million)
  • Fig. 56 Global Next Generation Sequencing Market for NGS Library Preparation Kits, 2018 - 2030 (USD Million)
  • Fig. 57 Global Next Generation Sequencing Market for Semi-automated Library Preparation, 2018 - 2030 (USD Million)
  • Fig. 58 Global Next Generation Sequencing Market for Automated Library Prepartion, 2018 - 2030 (USD Million)
  • Fig. 59 Global Next Generation Sequencing Market for Others, 2018 - 2030 (USD Million)
  • Fig. 60 Global Next Generation Sequencing Market for Sequencing, 2018 - 2030 (USD Million)
  • Fig. 61 Global Next Generation Sequencing Market for NGS Data Analysis, 2018 - 2030 (USD Million)
  • Fig. 62 Global Next Generation Sequencing Market for NGS Primary Data Analysis, 2018 - 2030 (USD Million)
  • Fig. 63 Global Next Generation Sequencing Market for NGS Secondary Data Analysis, 2018 - 2030 (USD Million)
  • Fig. 64 Global Next Generation Sequencing Market for NGS Tertiary Data Analysis, 2018 - 2030 (USD Million)
  • Fig. 65 Global Next Generation Sequencing Market: End-use Movement Analysis
  • Fig. 66 Global Next Generation Sequencing Market for Academic Research, 2018 - 2030 (USD Million)
  • Fig. 67 Global Next Generation Sequencing Market for Clinical Research, 2018 - 2030 (USD Million)
  • Fig. 68 Global Next Generation Sequencing Market for Hospitals & Clinics, 2018 - 2030 (USD Million)
  • Fig. 69 Global Next Generation Sequencing Market for Pharma & Biotech Entities, 2018 - 2030 (USD Million)
  • Fig. 70 Global Next Generation Sequencing Market for Other users, 2018 - 2030 (USD Million)
  • Fig. 71 Regional Marketplace: Key Takeaways Other users
  • Fig. 72 Regional Outlook, 2023 & 2030
  • Fig. 73 Global Next Generation Sequencing Market: Region Movement Analysis
  • Fig. 74 North America Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 75 U.S. Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 76 Canada Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 77 Europe Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 78 Germany Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 79 UK Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 80 France Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 81 Italy Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 82 Spain Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 83 Denmark Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 84 Sweden Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 85 Norway Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 86 Asia Pacific Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 87 Japan Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 88 China Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 89 India Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 90 South Korea Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 91 Australia Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 92 Thailand Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 93 Latin America Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 94 Brazil Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 95 Mexico Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 96 Argentina Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 97 Middle East and Africa Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 98 South Africa Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 99 Saudi Arabia Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 100 UAE Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 101 Kuwait Next Generation Sequencing Market, 2018 - 2030 (USD Million)